Diamond Biofund Inc. is a biotechnology venture capital firm that invests in life sciences and medical innovation. The company focuses on new drug development, advanced medical devices, medical services, medical distribution channels, and agricultural biotechnology. It provides portfolio companies with support in corporate governance, technical research, clinical execution, commercial development, and capital market integration. Diamond Biofund Inc. was founded with founding shareholders including China Biotech, Fubon Financial Holding, Taishin Financial Holding, and Ruentai Group. The company operates through subsidiaries Diamond No.1 Investment Co., Ltd. and Diamond High-Tech Investment Co., Ltd. It targets globally competitive investment targets to accelerate value realization for its shareholders.

Summarised from the company's own disclosures, fiscal year ended Oct 2026

Industry Asset Management Homepage diamondbiofund.com
Sector Financial Services IR page diamondbiofund.com/investor-relations/corporate-governance/boss
Tags
venture capital, biotechnology, life sciences, medical devices, new drug development, agricultural biotechnology, clinical execution, corporate governance, Diamond No.1 Investment Co. Ltd., Diamond High-Tech Investment Co. Ltd.
Press page —

Metrics

Valuation  
Market cap NT$ 10.973B
Market cap (USD) $ 333.06M
P/E 4.48
PEG —
P/BV 0.94
P/S 4.28
P/OCF 9.63
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE -12.0%
ROI -12.7%
ROIC -10.0%
Profit margin —
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score -14.3%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue -1.073B -2.229B -2.44B 1.016B 3.064B
Net profit -1.175B -2.518B -2.583B 797.781M 2.852B

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Share price 16.5 32.7 48.8 — —
Price performance 12m -0.5 -0.33 — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Diamond Biofund Inc. (ticker 6901.TW), listed in Taiwan.

ETFs Holding Diamond Biofund Inc.

ETF Weight in ETF Shares Market value As of
AVEE 0.01% 23,000 $ 9,802.83 Nov 16, 2026